Black Rock Inc. Tempest Therapeutics, Inc. Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Tempest Therapeutics, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 550,241 shares of TPST stock, worth $451,197. This represents 0.0% of its overall portfolio holdings.
Number of Shares
550,241
Previous 508,195
8.27%
Holding current value
$451,197
Previous $1.99 Million
39.36%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding TPST
# of Institutions
39Shares Held
6.35MCall Options Held
34.9KPut Options Held
148K-
Versant Venture Management, LLC San Francisco, CA3.51MShares$2.88 Million4.35% of portfolio
-
Jane Street Group, LLC New York, NY493KShares$404,3370.0% of portfolio
-
Geode Capital Management, LLC Boston, MA354KShares$290,5060.0% of portfolio
-
Ubs Group Ag196KShares$160,4540.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny190KShares$155,3940.0% of portfolio
About Tempest Therapeutics, Inc.
- Ticker TPST
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 10,418,900
- Market Cap $8.54M
- Description
- Tempest Therapeutics Inc., a clinical-stage oncology company, engages in developing small molecule therapeutics to treat cancer. The company's two clinical programs are TPST-1495, a dual antagonist of EP2 and EP4, receptors of prostaglandin E2, and is currently in a Phase 1 trial in solid tumors; and TPST-1120, a selective antagonist of peroxiso...